NORD and BIO (Biotechnology Industry Organization) have joined forces to bring the rare disease community the best information possible in this webinar.
Patients can be a powerful force in the drug development process. This webinar will help you understand how a drug development process. This webinar will help you understand how a drug comes to market and what you can do as a patient or advocate to support new and improved treatment options.
Patients, Caregivers, and Advocates will learn:
Guest Speakers include:
Steven Grossman, President, HPS Group LLC
In addition to being an analyst, counselor and communicator, Steve is often a facilitator for strategic planning and program development meetings. He speaks and writes on a wide range of policy topics, including communicating with FDA, incentives for drug development, understanding health care financing programs, and the impact of information technology on health care.
Kay Holcombe, SVP for Science Policy, BIO
Kay works to develop appropriate responses to government initiatives that affect the biopharmaceutical industry broadly. She works with government relations, policy, and legal staff, and BIO member companies to develop and implement policies that advance the public health. Prior to joining BIO, she was Vice President, FDA Alliances and Federal Agency Relations, at Sanofi and Vice President for Government Relations at Genzyme Corporation.
Those interested MUST pre-register